D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N

Alicia V. Binda, Nadine Kabbani, Ridwan Lin, Robert Levenson

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

We identified protein 4.1N as a D2-like dopamine receptor-interacting protein in a yeast two-hybrid screen. Protein 4.1N is a neuronally enriched member of the 4.1 family of cytoskeletal proteins, which also includes protein 4.1R of erythrocytes and the 4.1G and 4.1B isoforms. The interaction of protein 4.1N was specific for the D2 and D3 dopamine receptors and was independently confirmed in pulldown and colmmunoprecipitation assays. Deletion mapping localized the site of dopamine receptor/protein 4.1N interaction to the N-terminal segment of the third intracellular domain of D2 and D3 receptors and the carboxyl-terminal domain of protein 4.1N. D2 and D3 receptors were also found to interact with the highly conserved carboxyl-terminal domain of proteins 4.1R, 4.1G, and 4.1B. Immunofluorescence studies show that protein 4.1N and D2 and D3 dopamine receptors are expressed at the plasma membrane of transfected human embryonic kidney 293 and mouse neuroblastoma Neuro2A cells. However, expression of D2 or D3 receptors with a protein 4.1N truncation fragment reduces the level of D2 and D3 receptor expression at the plasma membrane. These results suggest that protein 4.1N/dopamine receptor interaction is required for localization or stability of dopamine receptors at the neuronal plasma membrane.

Original languageEnglish (US)
Pages (from-to)507-513
Number of pages7
JournalMolecular pharmacology
Volume62
Issue number3
DOIs
StatePublished - Sep 1 2002

Fingerprint

Dopamine D3 Receptors
Dopamine D2 Receptors
Dopamine Receptors
Cell Membrane
Receptor-Interacting Protein Serine-Threonine Kinases
Cytoskeletal Proteins
erythrocyte membrane protein band 4.1-like 1
Neuroblastoma
Fluorescent Antibody Technique
Dopamine
Protein Isoforms
Yeasts
Erythrocytes
Kidney

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Binda, Alicia V. ; Kabbani, Nadine ; Lin, Ridwan ; Levenson, Robert. / D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. In: Molecular pharmacology. 2002 ; Vol. 62, No. 3. pp. 507-513.
@article{d3cb3dedbb98467aaf07c551dc01f98d,
title = "D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N",
abstract = "We identified protein 4.1N as a D2-like dopamine receptor-interacting protein in a yeast two-hybrid screen. Protein 4.1N is a neuronally enriched member of the 4.1 family of cytoskeletal proteins, which also includes protein 4.1R of erythrocytes and the 4.1G and 4.1B isoforms. The interaction of protein 4.1N was specific for the D2 and D3 dopamine receptors and was independently confirmed in pulldown and colmmunoprecipitation assays. Deletion mapping localized the site of dopamine receptor/protein 4.1N interaction to the N-terminal segment of the third intracellular domain of D2 and D3 receptors and the carboxyl-terminal domain of protein 4.1N. D2 and D3 receptors were also found to interact with the highly conserved carboxyl-terminal domain of proteins 4.1R, 4.1G, and 4.1B. Immunofluorescence studies show that protein 4.1N and D2 and D3 dopamine receptors are expressed at the plasma membrane of transfected human embryonic kidney 293 and mouse neuroblastoma Neuro2A cells. However, expression of D2 or D3 receptors with a protein 4.1N truncation fragment reduces the level of D2 and D3 receptor expression at the plasma membrane. These results suggest that protein 4.1N/dopamine receptor interaction is required for localization or stability of dopamine receptors at the neuronal plasma membrane.",
author = "Binda, {Alicia V.} and Nadine Kabbani and Ridwan Lin and Robert Levenson",
year = "2002",
month = "9",
day = "1",
doi = "10.1124/mol.62.3.507",
language = "English (US)",
volume = "62",
pages = "507--513",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. / Binda, Alicia V.; Kabbani, Nadine; Lin, Ridwan; Levenson, Robert.

In: Molecular pharmacology, Vol. 62, No. 3, 01.09.2002, p. 507-513.

Research output: Contribution to journalArticle

TY - JOUR

T1 - D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N

AU - Binda, Alicia V.

AU - Kabbani, Nadine

AU - Lin, Ridwan

AU - Levenson, Robert

PY - 2002/9/1

Y1 - 2002/9/1

N2 - We identified protein 4.1N as a D2-like dopamine receptor-interacting protein in a yeast two-hybrid screen. Protein 4.1N is a neuronally enriched member of the 4.1 family of cytoskeletal proteins, which also includes protein 4.1R of erythrocytes and the 4.1G and 4.1B isoforms. The interaction of protein 4.1N was specific for the D2 and D3 dopamine receptors and was independently confirmed in pulldown and colmmunoprecipitation assays. Deletion mapping localized the site of dopamine receptor/protein 4.1N interaction to the N-terminal segment of the third intracellular domain of D2 and D3 receptors and the carboxyl-terminal domain of protein 4.1N. D2 and D3 receptors were also found to interact with the highly conserved carboxyl-terminal domain of proteins 4.1R, 4.1G, and 4.1B. Immunofluorescence studies show that protein 4.1N and D2 and D3 dopamine receptors are expressed at the plasma membrane of transfected human embryonic kidney 293 and mouse neuroblastoma Neuro2A cells. However, expression of D2 or D3 receptors with a protein 4.1N truncation fragment reduces the level of D2 and D3 receptor expression at the plasma membrane. These results suggest that protein 4.1N/dopamine receptor interaction is required for localization or stability of dopamine receptors at the neuronal plasma membrane.

AB - We identified protein 4.1N as a D2-like dopamine receptor-interacting protein in a yeast two-hybrid screen. Protein 4.1N is a neuronally enriched member of the 4.1 family of cytoskeletal proteins, which also includes protein 4.1R of erythrocytes and the 4.1G and 4.1B isoforms. The interaction of protein 4.1N was specific for the D2 and D3 dopamine receptors and was independently confirmed in pulldown and colmmunoprecipitation assays. Deletion mapping localized the site of dopamine receptor/protein 4.1N interaction to the N-terminal segment of the third intracellular domain of D2 and D3 receptors and the carboxyl-terminal domain of protein 4.1N. D2 and D3 receptors were also found to interact with the highly conserved carboxyl-terminal domain of proteins 4.1R, 4.1G, and 4.1B. Immunofluorescence studies show that protein 4.1N and D2 and D3 dopamine receptors are expressed at the plasma membrane of transfected human embryonic kidney 293 and mouse neuroblastoma Neuro2A cells. However, expression of D2 or D3 receptors with a protein 4.1N truncation fragment reduces the level of D2 and D3 receptor expression at the plasma membrane. These results suggest that protein 4.1N/dopamine receptor interaction is required for localization or stability of dopamine receptors at the neuronal plasma membrane.

UR - http://www.scopus.com/inward/record.url?scp=0036765857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036765857&partnerID=8YFLogxK

U2 - 10.1124/mol.62.3.507

DO - 10.1124/mol.62.3.507

M3 - Article

C2 - 12181426

AN - SCOPUS:0036765857

VL - 62

SP - 507

EP - 513

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 3

ER -